The CELLSEARCH Circulating Tumor Cell Test from Janssen Diagnostics was the first diagnostic test to catch and detect circulating tumor cells (CTCs). The technology is used in patients with metastatic breast, prostate, or colorectal cancer. The system's analysis of these CTCs--cells that have come off of solid cancer tumors and are circulating in the blood--is used alongside other clinical information to give patients and clinicians usable information about cancer prognosis.

CELLSEARCH was the first winner of the Prix Galien "Best Medical Technology" award, an honor it received in 2009.

Continue on to "How Smart Clothing Is Made"

Learn about "How to Set Your Connected Health Solution Apart" at BIOMEDevice San Jose, December 7-8.